Bioeq AG
Akos Mile, FCCA, currently serves as Finance Director at Bioeq AG since September 2022, after previously holding the position of Finance Manager. Prior to joining Bioeq AG, Akos Mile worked at PwC Switzerland from December 2016 to September 2022, advancing from Audit Senior to Audit Manager. Akos Mile's experience also includes roles at EY as an Audit Senior and Audit Assistant between August 2014 and October 2016, and as Sales Controller at profine GmbH from 2013 to July 2014. Earlier in the career, Akos Mile held the position of Upstream Accountant at ExxonMobil from August 2010 to July 2012. Akos Mile obtained a Master of Economics degree from Corvinus University of Budapest, completing the program in 2010.
Previous companies
This person is not in any teams
This person is not in any offices
Bioeq AG
Bioeq AG is a Swiss biopharmaceutical joint venture backed by the leading biosimilar developers Polpharma Biologics Group and Formycon AG and is based in Zug. We license, develop and commercialise a biosimilar, which is a successor product of Lucentis® (ranibizumab), a successful branded biopharmaceutical. We are a young and dynamic company, supported by an international network of experts. Bioeq AG out-licenses its products to established international pharmaceutical companies who ensure local distribution in each territory.